Air Products Chemicals Inc
For the period ended Mar 31, 2024. Filed Apr 30, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed Apr 30, 2024
Contents
Share-Based Compensation
- SHARE-BASED COMPENSATION
Our outstanding share-based compensation programs include deferred stock units and stock options. During the six months ended 31 March 2024, we granted market-based and time-based deferred stock units. Under all programs, the terms of the awards are fixed at the grant date. We issue shares from treasury stock upon the payout of deferred stock units and the exercise of stock options. As of 31 March 2024, there were 1.0 million shares available for future grant under our Long-Term Incentive Plan ("LTIP"), which is shareholder approved.
Share-based compensation cost recognized on the consolidated income statements is summarized below:
| Three Months Ended · Six Months Ended | ||||
|---|---|---|---|---|
| 31 March | 31 March | |||
| 2024 | 2023 | 2024 | 2023 | |
| Before-tax share-based compensation cost | $14.8 | $15.5 | $28.4 | $32.4 |
| Income tax benefit | (3.6) | (3.9) | (6.9) | (7.9) |
| After-tax share-based compensation cost | $11.2 | $11.6 | $21.5 | $24.5 |
Before-tax share-based compensation cost is primarily included in "Selling and administrative expense" on our consolidated income statements. The amount of share-based compensation cost capitalized in the first six months of fiscal years 2024 and 2023 was not material.
Deferred Stock Units
During the six months ended 31 March 2024, we granted 102,120 market-based deferred stock units. The market-based deferred stock units are earned over the performance period beginning 1 October 2023 and ending 30 September 2026, conditioned on the level of our total shareholder return in relation to the S&P 500 Index over thethree-year performance period.
The market-based deferred stock units had an estimated grant-date fair value of $302.10 per unit, which was estimated using a Monte Carlo simulation model. The model utilizes multiple input variables that determine the probability of satisfying the market condition stipulated in the grant and calculates the fair value of the awards. We generally expense the grant-date fair value of these awards on a straight-line basis over the vesting period. The calculation of the fair value of market-based deferred stock units used the following assumptions:
| Expected volatility | 25.0% |
|---|---|
| Risk-free interest rate | 4.3% |
| Expected dividend yield | 2.6% |
In addition, during the six months ended 31 March 2024, we granted 139,425 time-based deferred stock units at a weighted average grant-date fair value of $272.05.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.